In the present study, our team decided to investigate by flow cytometry the activity of the executioner caspases 3/7 in MCF-7 and MDA-MB-231 breast cancer cells after 24 h of treatment with cisplatin and EDA-71 at two concentrations (1.5 and 3 μM). Here, CASP3 is linked to breast carcinoma.